AZ Brushes Off Vaccine Criticism, Awaits US Readout

WHO Endorsement Counters Fears

 
• By Andrew McConaghie
  
AZ Vaccines
AstraZeneca's COVID-19 vaccine: fears on efficacy could be allayed by US Phase III results, expected within the next few weeks.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D